Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study

Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study

BackgroundTreatment-resistant schizophrenia is a major disabling illness which often proves challenging to manage in a secondary care setting. The National Psychosis Unit (NPU) is a specialised tertiary in-patient facility that provides evidence-based, personalised, multidisciplinary interventions f...

Full description

Bibliographic Details
Main Authors:	Cecilia Casetta, Fiona Gaughran, Ebenezer Oloyede, Juliana Onwumere, Megan Pritchard, Sukhi S. Shergill, Eromona Whiskey, James Hunter MacCabe
Format:	Article
Language:	English
Published:	Cambridge University Press 2020-09-01
Series:	BJPsych Open
Subjects:	Treatment-resistant psychosis tertiary service personalised care clozapine specialist service
Online Access:	https://www.cambridge.org/core/product/identifier/S2056472420000514/type/journal_article

Similar Items

Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis
by: Alastair Green, et al.
Published: (2019-05-01)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
by: Ebenezer Oloyede, et al.
Published: (2023-06-01)

DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia
by: Eilis Hannon, et al.
Published: (2021-02-01)

What is the best approach for patients with prolonged duration of untreated psychosis (DUP) - about 2 clinical cases with dup longer than 10 years
by: R. Gomes, et al.
Published: (2021-04-01)

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
by: Lally J, et al.
Published: (2016-11-01)

Clozapine prescribing during follow-up of a first-episode psychosis cohort
by: R. Rowntree, et al.
Published: (2021-04-01)

Underuse of recommended treatments among people living with treatment-resistant psychosis
by: Julia M. Lappin, et al.
Published: (2022-09-01)

Ethnic inequalities in treatment with clozapine
by: D. Fonseca De Freitas, et al.
Published: (2022-06-01)

Proof–of–concept evidence for high–density EEG investigation of sleep slow wave traveling in First-Episode Psychosis
by: Anna Castelnovo, et al.
Published: (2024-03-01)

CLEAR – clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings
by: C. Casetta, et al.
Published: (2024-02-01)

A Synthetic Literature Review on the Management of Emerging Treatment Resistance in First Episode Psychosis: Can We Move towards Precision Intervention and Individualised Care?
by: Siân Lowri Griffiths, et al.
Published: (2020-11-01)

Impact of medications, mood state, and electrode placement on ECT outcomes in treatment-refractory psychosis
by: Nicholas J. Ainsworth, et al.
Published: (2022-09-01)

Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis
by: Yerye Gibrán Mayén-Lobo, et al.
Published: (2021-02-01)

The relationship between combined antipsychotic use and clinical features in schizophrenia spectrum patients treated in inpatient ward: A retrospective study
by: U. Baklaci
Published: (2021-04-01)

The Influence of Trial-By-Trial Feedback on Trust in Health, First-Episode and Chronic Psychosis
by: Imke L. J. Lemmers-Jansen, et al.
Published: (2022-08-01)

Abnormalities in one-carbon metabolism in young patients with psychosis
by: Ariel Frajerman, et al.
Published: (2023-02-01)

Editorial: Psychosis in low- and middle-income countries (LMIC)
by: Manuela Russo, et al.
Published: (2024-04-01)

Editorial: Treatment resistance in psychotic disorders
by: Santanu Nath, et al.
Published: (2023-03-01)

Psychosis treatment using Clozapine in velocardiofacial syndrome
by: Ana Raquel Faria, et al.
Published: (2022-09-01)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
by: Sofia Redaelli, et al.
Published: (2022-07-01)

Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study
by: Miquel Bioque, et al.
Published: (2020-01-01)

Developing prediction models for symptom severity around the time of discharge from a tertiary-care program for treatment-resistant psychosis
by: Lik Hang N. Lee, et al.
Published: (2023-06-01)

The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
by: Licia Vellucci, et al.
Published: (2023-08-01)

Croatian Models and Experience in First-Episode Psychosis Treatment
by: A. Savic, et al.
Published: (2022-06-01)

Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal
by: Felice Iasevoli, et al.
Published: (2023-03-01)

Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report
by: Maxine Yang, et al.
Published: (2023-06-01)

Clozapine-induced, dilated cardiomyopathy: a case report
by: Sarah Longhi, et al.
Published: (2017-07-01)

Prevalence of treatment resistance and clozapine use in early intervention services
by: Imogen Stokes, et al.
Published: (2020-09-01)

Sustained long-term improvement with clozapine in schizophrenia Clozapina na esquizofrenia grave: melhora duradoura e sustentada
by: RICARDO DE OLIVEIRA-SOUZA, et al.
Published: (1999-03-01)

Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021-07-01)

Homicide in the context of psychosis: analysis of prior service utilisation and age at onset of illness and violence
by: Stephanie R. Penney, et al.
Published: (2023-09-01)

Patient violence towards their family carers: A qualitative exploration of carers’ experiences in psychosis
by: E. Wildman, et al.
Published: (2022-06-01)

Making meaning of trauma in psychosis
by: Nienke van Sambeek, et al.
Published: (2023-11-01)

Experiences of service transitions in Australian early intervention psychosis services: a qualitative study with young people and their supporters
by: Alyssa Milton, et al.
Published: (2022-12-01)

Co-producing research on psychosis: a scoping review on barriers, facilitators and outcomes
by: C. E. Jakobsson, et al.
Published: (2023-08-01)

Don’t blame psychosis, blame the lack of services: a message for early intervention from the Greek standard care model
by: Stefanos Dimitrakopoulos, et al.
Published: (2022-08-01)

Comparing interventions for early psychosis: a systematic review and component network meta-analysisResearch in context
by: Ryan Williams, et al.
Published: (2024-04-01)

The critical period in patients with psychosis: "Duration of Untreated Psychosis" and social determinants
by: Gamze Akçay Oruç, et al.
Published: (2018-06-01)

The co-construction and emotion management of hope within psychosis services
by: Patrick Brown, et al.
Published: (2024-01-01)

Acute family marital psychosis
by: D. Falfel, et al.
Published: (2021-04-01)